Primary Care Clinics in Morrison, IL Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Mercyone Morrison Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 635 E Lincolnway, Morrison, IL 61270 Phone: 815-772-7491 Fax: 815-772-7891 |
Morrison Community Hospital Family Care Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 303 N Jackson St, Morrison, IL 61270 Phone: 815-772-5511 Fax: 815-772-5599 |
Morrison Clinic Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 105 S Heaton St, Morrison, IL 61270 Phone: 815-772-8100 |
Morrison Family Health Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 635 E Lincolnway, Morrison, IL 61270 Phone: 815-772-7491 Fax: 815-772-7891 |
Morrison Community Hospital Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 635 E Lincolnway, Morrison, IL 61270 Phone: 815-772-7491 Fax: 815-772-7891 |
News Archive
FDA clears AliveCor's automated detectors that record and display ECG rhythm
AliveCor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for two new algorithms giving users instant feedback on their electrocardiogram (ECG) recordings and expanding its automated interpretation service offerings.
Cell Therapeutics files 2009 Annual Report on Form 10-K
Cell Therapeutics, Inc. today announced that it has filed its Annual Report on Form 10-K for the year ended December 31, 2009. This filing is available for review on CTI's website at www.CellTherapeutics.com, or on the Securities and Exchange Commission's website at www.sec.gov.
NeoStem to present adult stem cell technologies at Stem Cell Investor & Executive Networking Conference
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that the Company has been invited to present its adult stem cell technologies at the Stem Cell Investor & Executive Networking Conference Event (SCIENCE) in New York City on June 1, 2010. SCIENCE is designed to bring together investors with industry executives, visionary researchers and clinicians and other stakeholders to highlight opportunities and discuss advances in the stem cell field.
Fidaxomicin, CDA1/CDB1 effective for treating CDI : Report
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in first- and second-line treatment of Clostridium difficile infection, nearly 70 percent of surveyed infectious disease specialists and internists will use Optimer's fidaxomicin and nearly half will use Medarex/Merck's CDA1 and CDB1, one year after the launch of these agents. The lower recurrent/relapse rate associated with fidaxomicin and CDA1/CDB1 is the most influential attribute surveyed clinicians cite in their decisions to prescribe these emerging agents for CDI.
Breakthrough study opens door to design of whitening compounds for removing skin discolorations
Spots resulting from too much sun exposure and other effects of dysfunctional melanin production may become a thing of the past.
› Verified 9 days ago